SCHEMBL18374383

SCHEMBL18374383

COC(=O)[C@H](Cc1ccc(O)cc1)NC(=O)CNC(=O)[C@@H]1CCCN1C(=O)[C@H](C)N

nearest known ligand 0.52

Predicted protein targets (top 4)

geneUniProtsupporting neighboursconfidence
▸ OPRM1 P35372 4/20 0.50
▸ OPRD1 P41143 3/20 0.50
▸ SLC6A2 P23975 1/20 0.48
▸ OPRK1 P41145 1/20 0.47

Click a target to see other patent compounds predicted against it — the reverse direction, in place.

Similar compounds — the chemically nearest patent molecules

Nearest neighbours by Morgan-fingerprint cosine across the patent-compound collection, with each neighbour's top predicted target and the predicted targets it shares with this molecule.

Compoundsimilaritytop predictedshared targets
SCHEMBL20415563 0.87 CMA1 (0.51) —
SCHEMBL18374166 0.85 ALDH1A1 (0.49) —
SCHEMBL18374388 0.84 ACE (0.49) OPRM1OPRD1
SCHEMBL18374556 0.84 CMA1 (0.44) OPRM1OPRD1
SCHEMBL29565052 0.83 OPRM1 (0.54) OPRM1OPRD1SLC6A2
SCHEMBL28918688 0.83 ACE (0.54) OPRM1OPRD1
SCHEMBL28918687 0.83 ACE (0.54) OPRM1OPRD1
SCHEMBL21581709 0.82 OPRM1 (0.58) OPRM1OPRD1
SCHEMBL26454172 0.82 OPRM1 (0.58) OPRM1OPRD1
SCHEMBL29496921 0.81 SLC6A2 (0.66) OPRM1OPRD1SLC6A2

Similarity is cosine over the 2,048-bit Morgan fingerprint (≈ Tanimoto). Identical fingerprints score 1.00.

Patent provenance — the patents this molecule appears in, and who filed them

Claimed or disclosed in 4 patents. claimed = in the patent's claims; disclosed = body only.

PatentTitleAssigneePublishedPriorityFilingCountryStatus
US-11365215-B2 Method for preventing, improving, or treating inflammatory bowel disease KOREA RESEARCH INSTITUTE OF CHEMICAL TECHNOLOGY (KR) 2022-06-21 — — US disclosed
US-20180208625-A1 METHOD FOR PREVENTING, IMPROVING, OR TREATING INFLAMMATORY BOWEL DISEASE KOREA RESEARCH INSTITUTE OF CHEMICAL TECHNOLOGY (KR) 2018-07-26 — — US disclosed
US-20170008924-A1 PYRROLIDINE CARBOXAMIDO DERIVATIVES AND METHODS FOR PREPARING AND USING THE SAME Research & Business Foundation Sungkyunkwan University (KR) 2017-01-12 — — US disclosed
WO-2017008033-A1 PYRROLIDINE CARBOXAMIDO DERIVATIVES AND METHODS FOR PREPARING AND USING THE SAME Reasearch & Business Foundation Sungkyunkwan University (KR) 2017-01-12 — — WO disclosed

Patent text — is the patent's own abstract consistent with the prediction?

For each of this compound's patents that has machine-readable text (3 of them — usually the abstract, not the full specification), we ask MedCPT which protein the text reads most about, and where the chemistry-predicted target lands among 4885 human targets. A high rank means the patent's own wording is consistent with the prediction — a weak, independent signal, not proof of activity.

PatentTitleText reads most aboutPredicted target · text-rank
US-20180208625-A1 METHOD FOR PREVENTING, IMPROVING, OR TREATING INFLAMMATORY BOWEL DISEASE SI, NOD2, TNF OPRM1 3659/4885OPRD1 2585/4885SLC6A2 4635/4885
US-20170008924-A1 PYRROLIDINE CARBOXAMIDO DERIVATIVES AND METHODS FOR PREPARING AND USING THE SAME NOD2, SI, APC OPRM1 2788/4885OPRD1 1595/4885SLC6A2 4862/4885
US-11365215-B2 Method for preventing, improving, or treating inflammatory bowel disease SI, NOD2, TNF OPRM1 3659/4885OPRD1 2585/4885SLC6A2 4635/4885

“Text reads most about” is the patent abstract's nearest protein in MedCPT space (background-debiased). Only ~1.4% of patents have machine-readable text, so most compounds won't have this panel.

Send feedback